`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`FRESENIUS KABI USA, LLC and FRESENIUS KABI SWISSBIOSIM GmbH
`Petitioners,
`v.
`AMGEN, INC. and AMGEN MANUFACTURING LIMITED
`Patent Owner
`______________
`
`Case IPR2019-00971
`Patent 9,856,287 B1
`
`Title: REFOLDING PROTEINS USING A CHEMICALLY CONTROLLED
`REDOX STATE
`______________
`
`PETITIONERS’ MOTION FOR PRO HAC VICE ADMISSION OF
`ROBERT V. CERWINSKI UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`IPR2019-00971
`
`I.
`
`STATEMENT OF THE PRECISE RELIEF REQUESTED
`Pursuant to the Board’s “Notice of Filing Date Accorded /Defective
`
`Petition,” dated December 15, 2015 (Paper No. 3), authorizing the parties to file
`
`motions for pro hac vice admission under 37 C.F.R. § 42.10(c), Petitioners
`
`Fresenius Kabi USA, LLC and Fresenius Kabi SwissBioSIM GmBH respectfully
`
`request that the Board allow Robert V. Cerwinski to appear pro hac vice on their
`
`behalf in this proceeding. Patent Owner has stated that it will not oppose this
`
`motion.
`
`II. REASONS THE REQUESTED RELIEF SHOULD BE GRANTED
`As set forth in the Statement of Material Facts below, and as required by 37
`
`C.F.R. § 42.10(c), Petitioners have demonstrated good cause to admit Mr.
`
`Cerwinski pro hac vice in this proceeding. In particular, Petitioners’ lead counsel
`
`is a registered practitioner, and Mr. Cerwinski is an experienced litigating attorney
`
`having an established familiarity with the subject matter at issue in this proceeding.
`
`Furthermore, this motion is being filed more than twenty one days after
`
`service of the petition; includes a statement of facts showing good cause for the
`
`Board to recognize Mr. Cerwinski pro hac vice; and is being filed concurrently
`
`with Exhibit 1047, the Declaration of Robert V. Cerwinski in Support of
`
`Petitioners’ Motion for Pro Hac Vice Admission of Robert V. Cerwinski
`
`(“Cerwinski Decl.”), all in accordance with the “Order Authorizing Motion for Pro
`
`
`
`
`1
`
`
`
`IPR2019-00971
`
`Hac Vice Admission” in Unified Patents, Inc. v. Parallel Iron, LLC, IPR2013-
`
`00639, Paper 7 at 3 (P.T.A.B. Oct. 15, 2013).
`
`III. STATEMENT OF MATERIAL FACTS
`37 C.F.R. § 42.10(c) provides that “[t]he Board may recognize counsel pro
`
`1.
`
`hac vice during a proceeding upon a showing of good cause, subject to the
`
`condition that lead counsel be a registered practitioner and to any other
`
`conditions as the Board may impose. For example, where the lead counsel is a
`
`registered practitioner, a motion to appear pro hac vice by counsel who is not a
`
`registered practitioner may be granted upon showing that counsel is an
`
`experienced litigating attorney and has an established familiarity with the subject
`
`matter at issue in the proceeding.”
`
`2. Huiya Wu, lead counsel for Petitioners Fresenius Kabi USA, LLC and
`
`Fresenius Kabi SwissBioSIM GmBH in this proceeding, is a registered
`
`practitioner holding Registration No. 44,411.
`
`3. As set forth in the Cerwinski Decl., Mr. Cerwinski is an experienced
`
`litigating attorney. Specifically, Mr. Cerwinski has over 20 years of experience
`
`representing clients in patent litigations, in United States District Courts and the
`
`Court of Appeals for the Federal Circuit. Mr. Cerwinski is a member in good
`
`standing of the Bar of the New York Bar. Mr. Cerwinski has never been
`
`suspended or disbarred from practice before any court or administrative body.
`
`
`
`
`2
`
`
`
`IPR2019-00971
`
`No application of Mr. Cerwinski for admission to practice before any court or
`
`administrative body has ever been denied. No sanctions or contempt citations
`
`have been imposed against Mr. Cerwinski by any court or Administrative Body.
`
`(Cerwinski Decl., ¶¶ 2-3).
`
`4. Mr. Cerwinski also has an established familiarity with the precise subject
`
`matter at issue in this proceeding. Petitioner and Patent Owner are currently
`
`involved in IPR2019-00971 concerning U.S. Patent No. 9,856,287 (the “’287
`
`patent”). Mr. Cerwinski is counsel for Fresenius Kabi USA, LLC and Fresenius
`
`Kabi SwissBioSIM GmBH, and in the course of that representation, he has
`
`developed a strong familiarity with the ’287 patent, its prosecution history, the
`
`general subject matter to which the ’287 patent is directed, and the prior art
`
`references relied upon by both Petitioner and Patent Owner. Additionally, Mr.
`
`Cerwinski has thoroughly reviewed the Petition and accompanying Exhibits
`
`submitted in this proceeding.
`
`5. Mr. Cerwinski has attested to the each of the requirements set forth in
`
`paragraph 2(b)(i)-(viii) of the “Order Authorizing Motion for Pro Hac Vice
`
`Admission” in Case IPR2013-00639, Paper 7 at 3. (Cerwinski Decl., ¶¶ 3, 4, 6-8,
`
`9-13).
`
`IV. CONCLUSION
`
`
`
`
`3
`
`
`
`IPR2019-00971
`
`In view of the foregoing, Petitioners respectfully submit that the
`
`requirements of 37 C.F.R. § 42.10(c) have been satisfied, and requests an Order
`
`permitting Robert V. Cerwinski to appear pro hac vice on its behalf in this
`
`proceeding.
`
`Dated: August 6, 2019
`
`Respectfully submitted,
`
`
`
`/Huiya Wu/
`Huiya Wu (Reg. No. 44,411)
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Tel: 212-813-8800
`Fax: 212-355-3333
`
`Counsel for Petitioners
`
`
`
`
`4
`
`
`
`
`
`CERTIFICATION OF SERVICE
`The undersigned hereby certifies that “PETITIONERS’ MOTION FOR
`
`PRO HAC VICE ADMISSION OF ROBERT V. CERWINSKI UNDER 37 C.F.R.
`
`§ 42.10(c)” and “EXHIBIT 1047 DECLARATION OF ROBERT V. CERWINSKI
`
`IN SUPPORT OF PETITIONERS’ MOTION FOR PRO HAC VICE ADMISSION
`
`OF ROBERT V. CERWINSKI UNDER 37 C.F.R. § 42.10(c)” were served
`
`electronically via email on the following:
`
`AMGEN, INC.
`Law - Patent Operations, M/S 35-1-B
`One Amgen Center Drive
`Thousand Oaks, CA 91320-1799
`
`
`Dated: August 6, 2019
`
`Respectfully submitted,
`
`
`
`/Huiya Wu/
`Huiya Wu (Reg. No. 44,411)
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Tel: 212-813-8800
`Fax: 212-355-3333
`
`Counsel for Petitioner
`
`
`
`